Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05240131
Title A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).
Recruitment Recruiting
Gender
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Galecto Biotech AB
Indications

lung adenocarcinoma

Therapies

Atezolizumab + GB1211

Age Groups: adult | senior
Covered Countries FRA | ESP

Additional content available in CKB BOOST